Microcap Ledger

Tickers · $CCEL

Cryo Cell International Inc $CCEL

By Microcap Ledger desk · CIK 0000862692

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
NYSE American
Sector
Services-Misc Health & Allied Services, NEC
Headquarters
Oldsmar, FL
Fiscal year end
November 30
Shares outstanding
8,062,650 [10-Q 2026-10-09]
as of 2026-10-08

Sources: [10-K 2026-02-27]

What the company doesAI summary of filing

Cryo-Cell International is a revenue-generating company that collects, processes, and cryopreserves umbilical cord blood and cord tissue for storage and potential future medical use. The company serves patients and their families who contract for these preservation services. The company generates revenue from storage fees and related services. The company is also pursuing product diversification through collaborative research partnerships, biopharmaceutical manufacturing, and clinic operations, though profitability from these initiatives remains uncertain. [10-K 2026-02-27]

Segments: Cord blood banking and cryopreservation, Cord tissue preservation, Biopharmaceutical manufacturing, Clinic operations

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
9 months to Aug 2026$23.28M$1.87M $3.64M$1.43M[10-Q 2026-10-09]
FY ended Nov 2025$31.57M−$2.43M $5.48M$319.0K[10-K 2026-02-27]
FY ended Nov 2024$31.99M$402.1K $6.01M$561.0K[10-K 2026-02-27]

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2025-02-288,082,159[10-K 2025-02-28]
2025-04-148,082,159[10-Q 2025-04-14]
2025-07-158,057,150[10-Q 2025-07-15]
2025-10-158,055,150[10-Q 2025-10-15]
2026-02-288,055,150[10-K 2026-02-27]
2026-04-148,055,150[10-Q 2026-04-14]
2026-07-158,062,650[10-Q 2026-07-15]
2026-10-088,062,650[10-Q 2026-10-09]

Listing status

Current status: 2 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-05-08. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

DateEventDetailsDeadlineFiling
2026-05-088-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2026-05-08]
2026-03-128-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2026-03-12]

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
DateInsiderTypeSharesPriceFiling
2026-08-05Portnoy Davidother600,191$1.33[4 2026-08-07]
2026-08-05Portnoy Davidother600,191$1.33[4 2026-08-07]
2026-05-28Taymans Jill Mexercise7,500$3.10[4 2026-05-29]
2025-11-21Portnoy Davidgrant800$4.04[4 2025-11-24]
2025-11-21Portnoy Davidgrant677$4.09[4 2025-11-24]
2025-11-21Portnoy Davidgrant406$4.09[4 2025-11-24]
2025-11-21Portnoy Davidgrant273$4.10[4 2025-11-24]
2025-11-20Portnoy Davidgrant289$4.00[4 2025-11-24]
2025-11-19Portnoy Davidgrant1,921$4.08[4 2025-11-19]
2025-11-18Portnoy Davidgrant640$4.09[4 2025-11-19]
2025-11-17Portnoy Davidgrant1,429$4.00[4 2025-11-19]

Catalysts and calendar

Recent filings and releases
DateTypeTitle
2026-10-0910-QQuarterly report
2026-09-148-KOther events
2026-07-1510-QQuarterly report
2026-07-0713D/ABeneficial ownership report (5%+ holder)
2026-05-088-KListing notice or transfer; Regulation FD disclosure
2026-04-1410-QQuarterly report
2026-03-2513DBeneficial ownership report (5%+ holder)
2026-03-128-KListing notice or transfer; Regulation FD disclosure
2026-02-2710-KAnnual report
2025-11-128-KOther events
2025-10-238-KMaterial agreement entered; New financial obligation
2025-10-1510-QQuarterly report

Facts as of . Small caps move fast; check the latest filings.